Wearable Health Solutions (WHSI) 10-K 20 Oct 23 2023 FY Annual report Financial data

Cover

Cover - USD ($)	12 Months Ended
	Jun. 30, 2023	Oct. 20, 2023
Cover [Abstract]
Document Type	10-K
Amendment Flag	false
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Jun. 30, 2023
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--06-30
Entity File Number	333-153290
Entity Registrant Name	Wearable Health Solutions, Inc.
Entity Central Index Key	0001443089
Entity Tax Identification Number	26-3534190
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	2901 Pacific Coast Highway
Entity Address, Address Line Two	Suite 200
Entity Address, City or Town	Newport Beach
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	92663
City Area Code	949
Local Phone Number	270.7460
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	No
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Public Float	$ 1,519,567
Entity Common Stock, Shares Outstanding		1,804,255,108
Document Financial Statement Error Correction [Flag]	false
Auditor Name	RBSM LLP
Auditor Location	New York, NY
Auditor Firm ID	587

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Jun. 30, 2023	Jun. 30, 2022
Current Assets
Cash and cash equivalents	$ 136,151	$ 70,505
Accounts receivable, net	379	0
Due from related parties	0	155,800
Accounts receivable, other	0	2,000
Inventory	8,555	7,064
Prepaid inventory	7,242	62,040
Total Current Assets	152,327	297,409
Property and equipment	38,689	41,651
Right-of-use assets	32,157	0
Total Assets	223,173	339,060
LIABILITIES AND SHAREHOLDERS' DEFICIT
COMMITMENTS AND CONTINGENCIES
Current Liabilities
Accounts payable	162,936	57,940
Accrued expenses and other current liabilities	517,067	374,278
Short-term lease liability	14,039	0
Related party debt, net	799,132	213,840
Deferred revenue	103,412	80,880
Line of credit	397,500	397,500
Notes payable	398,333	413,099
Notes payable - other	50,000	50,000
Notes payable - related party	170,000	170,000
Convertible notes - Leonite	246,148	0
Convertible notes - other	673,750	673,750
Stock subscription liability	249,500
Total Current Liabilities	3,781,817	2,431,287
Long-term lease liability	18,468	0
Total Liabilities	3,800,285	2,431,287
SHAREHOLDERS' DEFICIT
Common stock: $0.0001 par value; 3,000,000,000 shares authorized, 1,566,255,108 and 1,493,142,608 shares issued and outstanding as of June 30, 2023 and 2022, respectively	156,625	149,314
Common stock to be issued 169,767,499 and 35,602,500 shares as of June 30, 2023 and 2022, respectively	604,335	407,677
Additional paid-in capital	37,472,648	36,773,035
Accumulated deficit	(41,811,849)	(39,423,382)
Total Shareholders' Deficit	(3,577,112)	(2,092,227)
Total Liabilities and Shareholders' Deficit	223,173	339,060
Series A Preferred Stock [Member]
SHAREHOLDERS' DEFICIT
Preferred stock	1	1
Series B Preferred Stock [Member]
SHAREHOLDERS' DEFICIT
Preferred stock	1	1
Series C Preferred Stock [Member]
SHAREHOLDERS' DEFICIT
Preferred stock	684	684
Series D Preferred Stock [Member]
SHAREHOLDERS' DEFICIT
Preferred stock	43	43
Series E Preferred Stock [Member]
SHAREHOLDERS' DEFICIT
Preferred stock	$ 400	$ 400

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2023	Jun. 30, 2022
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	3,000,000,000	3,000,000,000
Common stock, shares issued	1,566,255,108	1,493,142,608
Common stock, shares outstanding	1,566,255,108	1,493,142,608
Common stock to be issued	169,767,499	35,602,500
Series A Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	100,000	100,000
Preferred stock, shares issued	688	688
Preferred stock, shares outstanding	688	688
Series B Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	62,500	62,500
Preferred stock, shares issued	9,938	9,938
Preferred stock, shares outstanding	9,938	9,938
Series C Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	6,944,445	6,944,445
Preferred stock, shares issued	6,838,889	6,838,889
Preferred stock, shares outstanding	6,838,889	6,838,889
Series D Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	500,000	500,000
Preferred stock, shares issued	425,000	425,000
Preferred stock, shares outstanding	425,000	425,000
Series E Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	4,000,000	4,000,000
Preferred stock, shares issued	4,000,000	4,000,000
Preferred stock, shares outstanding	4,000,000	4,000,000

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Income Statement [Abstract]
Revenue	$ 745,093	$ 1,045,890
Cost of sales	(477,430)	(568,409)
Gross profit	267,663	477,481
Operating expenses
Selling expense	133,999	372,553
Depreciation	12,404	8,349
Research and development expense	49,680	390,828
Consulting and professional fees	396,229	861,301
Insurance	70,350	87,576
Rent	20,350	16,605
Salaries and wages	1,530,511	11,375,405
General and administrative	348,281	409,444
Total operating expenses	2,561,804	13,522,061
Loss from operations	(2,294,141)	(13,044,580)
Other income / (expense), net
Other income	19,500	36,000
Interest income	1,501	0
Gain on debt extinguishment	0	96,145
Gain on settlement of accounts payable	0	156,616
Change in fair value of derivative instrument	0	(213,053)
Interest expense	(115,325)	(80,283)
Total other income (expense), net	(94,326)	(4,575)
Net loss before income taxes	(2,388,467)	(13,049,155)
Income taxes	0	0
Net loss	$ (2,388,467)	$ (13,049,155)

Consolidated Statements of Op_2

Consolidated Statements of Operations (Parenthetical) - $ / shares	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Income Statement [Abstract]
Net loss per common share, Basic	$ (0.00156)	$ (0.01202)
Net loss per common share, Diluted	$ (0.00156)	$ (0.01202)
Weighted average common shares outstanding, Basic	1,535,831,375	1,086,059,256
Weighted average common shares outstanding, Diluted	1,535,831,375	1,086,059,256

Consolidated Statement of Chang

Consolidated Statement of Changes in Shareholders' Deficit - USD ($)	Preferred Stock Series A [Member]	Preferred Stock Series B [Member]	Preferred Stock Series C [Member]	Preferred Stock Series D [Member]	Preferred Stock Series E [Member]	Series E To Be Issued [Member]	Common Stock [Member]	Common Stock To Be Issued [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Jun. 30, 2021	$ 1	$ 1	$ 684	$ 43	$ 190	$ 57,000	$ 64,708	$ 169,005	$ 22,732,295	$ (26,374,227)	$ (3,350,300)
Beginning balance, shares at Jun. 30, 2021	688	9,938	6,838,889	425,000	1,900,000	100,000	647,074,177	20,050,000
Loss for the period										(13,049,155)	(13,049,155)
Common stock for debt conversion							$ 6,641		671,066		677,707
Common stock for debt conversion, shares							66,418,431
Issuance of Shares for Cash							$ 35,000	$ (100,005)	3,465,004		3,399,999
Issuance of Shares for Cash, shares							350,000,000	(10,050,000)
Common stock for compensation							$ 40,965	$ 90,973	6,515,880		6,647,818
Common stock for compensation, shares							409,650,000	7,065,000
Common stock for officer compensation								$ 101,704			101,704
Common stock for officer compensation, shares								7,037,500
Preferred stock for compensation					$ 210	$ (57,000)			3,056,790		3,000,000
Preferred stock for compensation , shares					2,100,000	(100,000)
Stock for services							$ 2,000	$ (69,000)	362,000		295,000
Stock for services, shares							20,000,000	(10,000,000)
Shares sold for cash								$ 215,000			215,000
Shares sold for cash, shares								21,500,000
Subscriptions receivable									(30,000)		(30,000)
Ending balance, value at Jun. 30, 2022	$ 1	$ 1	$ 684	$ 43	$ 400		$ 149,314	$ 407,677	36,773,035	(39,423,382)	(2,092,227)
Ending balance, shares at Jun. 30, 2022	688	9,938	6,838,889	425,000	4,000,000		1,493,142,608	35,602,500
Loss for the period										(2,388,467)	(2,388,467)
Common stock for compensation							$ 700	$ (53,349)	89,300		36,651
Common stock for compensation, shares							7,000,000	(3,935,000)
Common stock for officer compensation							$ 961	$ (30,448)	123,196		93,709
Common stock for officer compensation, shares							9,612,500	4,287,499
Shares issued for services							$ 2,500	$ (44,481)	205,981		164,000
Shares issued for services, shares							20,000,000	(5,000,000)
Commitment shares - Leonite convertible notes								$ 49,936			49,936
Commitment shares - Leonite convertible notes, shares								15,000,000
Shares sold for cash							$ 3,150	$ 275,000	261,850		540,000
Shares sold for cash, shares							36,500,000	123,812,500
Fees incurred in connection with equity offering									(10,714)		(10,714)
Payment of subscription receivable									30,000		30,000
Ending balance, value at Jun. 30, 2023	$ 1	$ 1	$ 684	$ 43	$ 400		$ 156,625	$ 604,335	$ 37,472,648	$ (41,811,849)	$ (3,577,112)
Ending balance, shares at Jun. 30, 2023	688	9,938	6,838,889	425,000	4,000,000		1,566,255,108	169,767,499

Consolidated Statement of Cash

Consolidated Statement of Cash Flows - USD ($)	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash flow from operating activities
Net loss	$ (2,388,467)	$ (13,049,155)
Adjustment for non-cash charges and other items:
Depreciation	12,404	8,349
Amortization of deferred debt issuance costs	27,455	0
Amortization of debt discount	28,629	0
Stock compensation expense	294,360	10,044,522
Change in fair value of derivative instrument	0	213,053
Gain on settlement of accounts payable	0	(156,616)
Gain on debt extinguishment	0	(96,145)
Total adjustments	(2,025,619)	(3,035,992)
Changes in working capital
Decrease / (increase) in accounts receivables	1,621	25,694
Decrease / (increase) in inventory	(1,491)	(7,064)
Decrease / (increase) in prepaid inventory	54,798	(39,358)
Decrease / (increase) in prepaid expenses	0	10,000
(Decrease) / increase in trade and other payables	104,996	(117,320)
(Decrease) / increase in accrued expenses	143,139	84,281
(Decrease) / increase in accrued expenses - related party	420,552	0
(Decrease) / increase in deferred revenue	22,532	(27,418)
Total changes in working capital	746,147	(71,185)
Cash flow used in operating activities	(1,279,472)	(3,107,177)
Cash flow used in investing activities
Purchase of property, plant & equipment	(9,442)	(50,000)
Cash flow used in investing activities	(9,442)	(50,000)
Cash flow provided by financing activities
Proceeds received from related parties	320,540	(509,002)
Proceeds from issuance of convertible notes	240,000	25,000
Repayments of note payable	(14,766)	(720,145)
Proceeds from issuance of stock (net of subscriptions receivable) and stock subscription liability	819,500	3,584,399
Fees incurred in connection with equity offering	(10,714)	0
Cash flow from financing activities	1,354,560	2,380,252
Increase/(decrease) in cash and cash equivalents	65,646	(776,925)
Cash and cash equivalents at beginning of the year	70,505	847,430
Cash and cash equivalents at end of the year	136,151	70,505
Cash paid during the periods for:
Interest	0	0
Taxes	$ 0	$ 0

Nature and Continuance of Opera

Nature and Continuance of Operations	12 Months Ended
	Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature and Continuance of Operations	Note 1 -- Nature and Continuance of Operations Wearable Healthcare Solutions Inc. (the “Company”) was incorporated as Medical Alarm Concepts Holding, Inc. on June 4, 2008 under the laws of the State of Nevada. The Company was formed for the sole purpose of acquiring all of the membership units of Medical Alarm Concepts LLC, a Pennsylvania limited liability company (“Medical LLC”). On May 26, 2016, the Company filed its Amended and Restated Articles of Incorporation with the Secretary of State of the State of Nevada to change its name from “Medical Alarm Concepts, Inc.” to “Wearable Health Solutions Inc.” The Company provides mobile health (mHealth) products and services to be used by customers in case of an emergency. As a provider of personal emergency devices, the Company provides innovative wearable healthcare products, tracking services, and turn-key solutions that enable our users to be proactive with their health, as well as safe and protected. The Company’s flagship products are the iHelp devices, the 3G and the next generation iHelp MAX TM

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2 – Summary of Significant Accounting Policies Basis of Presentation Principles of Consolidation Use of Estimates Cash and Cash Equivalents Accounts Receivable 379 0 23,705 0 Concentration of Credit Risk Recognition of Revenues The Company’s revenues are derived principally from utilizing new technology in the medical alarm industry to provide 24-hour personal response monitoring services and related products to subscribers with medical- or age-related conditions. The Company recognizes revenue when it is realized or realizable and earned. For hardware sales, the Company recognizes revenues when the product is shipped. Customers are billed on Net 30 terms. For service revenue, the Company recognizes revenues when the time period for service is current. For customers who pay several months at a time, the Company records revenues for the month’s services and the balance of funds to deferred revenues, and records the balance of revenues as they become current. Schedule of revenues REVENUES 2023 2022 Hardware revenue $ 219,049 $ 134,045 Service revenue 526,044 911,845 TOTAL REVENUES $ 745,093 $ 1,045,890 Deferred Taxes ASC 740, Income Taxes, requires a company to first determine whether it is more likely than not (which is defined as a likelihood of more than fifty percent) that a tax position will be sustained based on its technical merits as of the reporting date, assuming that taxing authorities will examine the position and have full knowledge of all relevant information. A tax position that meets this more-likely-than-not threshold is then measured and recognized at the largest amount of benefit that is greater than fifty percent likely to be realized upon effective settlement with a taxing authority. The Federal and state income tax returns of the Company for 2023, 2022 and 2021 are subject to examination by the Internal Revenue Service and state taxing authorities for three (3) years from the date filed. Related party transactions a. Affiliates of the Company; b. Entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c. Trusts for the benefit of employees, such as pension and profit sharing trusts that are managed by or under the trusteeship of management; d. Principal owners of the Company; e. Management of the Company; f. Other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g. Other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests. The financial statements include disclosures of material related party transactions, other than compensation arrangements, expense allowances and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of financial statements is not required in those statements. The disclosures shall include: a. The nature of the relationship involved; b. A description of the transactions, including transactions to which no amounts or nominal amounts were ascribed for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c. The dollar amount of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d. Amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement. Fair value of financial instruments Level 1 Level 2 Level 3 From time to time, our financial instruments include cash, accounts payable and accrued expenses, convertible notes, lines of credit, and credit cards. Property and Equipment, Net When assets are retired or otherwise disposed of, the cost, accumulated depreciation and amortization are removed from the accounts and any resulting gain or loss is reflected in the consolidated statements of operations in the period realized. Maintenance and repairs that do not enhance or extend the asset’s useful life are charged to operating expenses as incurred. Impairment of Long-Lived Assets. The impairment test for identifiable indefinite-lived intangible assets consists of a comparison of the estimated fair value of the intangible asset with its carrying value. If the carrying value exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. The Company did not record any impairment losses on its long-lived assets as of June 30, 2023 or 2022. Software Development for internal use Research and Development - 49,680 390,828 Basic and Diluted Loss per Common Share Schedule of anti-dilutive shares Basis of conversion Dilution 2023 2022 Series A Convertible 688 shares outstanding 1 share A: 2 shares 1,376 1,376 Series B Convertible 9,938 shares outstanding 1 share B: 2 shares 19,876 19,876 Series C Convertible 6,838,889 shares outstanding 1 share C: 10 shares 68,388,890 68,388,890 Series D Convertible 425,000 shares outstanding 1 share D: 10 shares 4,250,000 4,250,000 Series E Convertible 4,000,000 shares outstanding 1 share E: 100 shares 400,000,000 400,000,000 472,660,142 472,660,142 Because the Company incurred losses for the past two years, the basic and diluted share bases will be presented as the same. For the years ended June 30, 2023 and 2022, the Company incurred losses of ($0.00156) and ($0.01202) per basic share and diluted share, respectively. Recent Accounting Pronouncements In August 2020, the FASB issued ASU No. 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (ASU 2020-06), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity’s own equity. Among other changes, ASU 2020-06 removes from U.S. GAAP the liability and equity separation model for convertible instruments with a cash conversion feature, and as a result, after adoption, entities will no longer separately present in equity an embedded conversion feature for such debt. Similarly, the embedded conversion feature will no longer be amortized into income as interest expense over the life of the instrument. Instead, entities will account for a convertible debt instrument wholly as debt unless (1) a convertible instrument contains features that require bifurcation as a derivative under ASC Topic 815, Derivatives and Hedging, or (2) a convertible debt instrument was issued at a substantial premium. Among other potential impacts, this change is expected to reduce reported interest expense, increase reported net income, and result in a reclassification of certain conversion feature balance sheet amounts from shareholders’ equity to liabilities as it relates to the Company’s convertible senior notes. Additionally, ASU 2020-06 requires the application of the if-converted method to calculate the impact of convertible instruments on diluted earnings per share (EPS), which is consistent with the Company’s accounting treatment under the current standard. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, with early adoption permitted for fiscal years beginning after December 15, 2020, and can be adopted on either a fully retrospective or modified retrospective basis. The Company early adopted the ASU on July 1, 2022, the beginning of its fiscal year. The Company does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the consolidated financial position, statements of operations and cash flows.

Going Concern

Going Concern	12 Months Ended
	Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	Note 3 – Going Concern The accompanying consolidated financial statements for the years ended June 30, 2023 and 2022 have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As of June 30, 2023, the Company has shown losses for the last two years, and has an accumulated deficit of ($ 41,811,849 39,423,382 During the year ended June 30, 2023, Company has net cash used in operating activities of $ 1,279,472 294,360 2,388,467 1,354,560 3,379,991 Management believes that the Company’s capital requirements will depend on many factors, including the success of the Company’s development efforts and its efforts to raise capital. Management also believes the Company needs to raise additional capital for working capital purposes. There can be no assurance that the Company will be able to obtain the additional capital resources necessary to implement its business plan or that any assumptions relating to its business plan will prove accurate. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The consolidated financial statements of the Company do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern.

Inventory, Prepaid Inventory an

Inventory, Prepaid Inventory and Prepaid Expenses	12 Months Ended
	Jun. 30, 2023
Inventory Disclosure [Abstract]
Inventory, Prepaid Inventory and Prepaid Expenses	Note 4 – Inventory, Prepaid Inventory and Prepaid Expenses The Company maintains some inventories in house and purchases some of its inventory overseas. Inventories, except for stock in transit are stated at the lower of cost and net realizable value. Stock in transit is valued at cost comprising invoice value plus other charges thereon. Net realizable is the estimated selling price in ordinary course of business less estimated costs of completion and selling expenses. The quantity of inventory may vary from time to time depending on the delivery schedule of overseas shipments. Inventory and prepaid inventory is valued at lower of cost or net realizable value, comprising invoice value plus other charges thereon. Net realizable value is the estimated selling price in the ordinary course of business, less estimated costs of completion and selling expenses. Prepaid expenses are valued at cost. Schedule of prepaid expenses 2023 2022 Inventory $ 8,555 $ 7,064 2023 2022 Prepaid inventory $ 7,242 $ 62,040

Property and Equipment

Property and Equipment	12 Months Ended
	Jun. 30, 2023
Property, Plant and Equipment [Abstract]
Property and Equipment	Note 5 – Property and Equipment The Company has $ 20,000 19,689 45,900 50,000 60 9,442 36 As of June 30, 2023 and June 30, 2022, the Company recorded $ 38,689 41,651 Schedule of property, plant and equipment 2023 2022 Furniture $ 20,000 $ 20,000 Office computers, equipment, software 19,689 19,689 Software development costs 45,900 45,900 Dealer portal 50,000 50,000 Furniture 9,443 – Property, plant, and equipment 145,032 135,589 Less accumulated depreciation (106,343 ) (93,938 ) Net property, plant, and equipment $ 38,689 $ 41,651 Depreciation expense was $12,404 and $8,349 for the year ended June 30, 2023 and 2022 respectively.

Accounts Payable and Accrued Ex

Accounts Payable and Accrued Expenses and liabilities	12 Months Ended
	Jun. 30, 2023
Payables and Accruals [Abstract]
Accounts Payable and Accrued Expenses and liabilities	Note 6 – Accounts Payable and Accrued Expenses and liabilities The Company recorded Accounts Payable of $ 162,936 57,940 Accrued expenses and other current liabilities are expenses that have been incurred but not yet paid and primarily include legal fees, audit fees, and other professional fees, as well as interest accrued in connection with credit lines and notes payable. The Company recorded $ 517,067 374,278

Notes Payable and Notes Payable

Notes Payable and Notes Payable - Other	12 Months Ended
	Jun. 30, 2023
Debt Disclosure [Abstract]
Notes Payable and Notes Payable - Other	Note 7 – Notes Payable and Notes Payable - Other Notes payable consists of line of credit, notes payable incurred by our subsidiary, notes payable-other, convertible notes payable, notes payable for stock purchases under Reg A, short-term notes payable and notes payable-BOAPIN portal, as follows: Schedule of short term notes payable June 30, 2023 2022 Notes from subsidiary $ 158,333 $ 174,243 Notes payable - Reg A deposits 140,000 138,856 Short term bridge loan 100,000 100,000 Total Notes Payable $ 398,333 $ 413,099 Notes Payable - Subsidiary The Company has various loans and credit lines outstanding. The credit line carries an interest rate of 6.24 9.24 10.90 Schedule of notes payable 2023 2022 Wells Fargo Loan $ 8,770 $ 8,770 On Deck Loan 139,569 139,569 Susquehanna Salt Loan – 10,500 Prosper Loans 9,994 9,994 Marcus Loan – 5,410 Notes payable - subsidiary $ 158,333 $ 174,243 Short term bridge loan - COHEN On July 31, 2020, the Company secured a $ 500,000 12 At June 30, 2021, the Company recorded short term note payable of $ 500,000 55,027 300,000 100,000 At June 30, 2023 and 2022, the Company recorded a short term note payable of $ 100,000 12,000 21,649 88,677 76,677 Note payable – stock purchases under Reg A At June 30, 2023 and 2022 the Company has recorded $ 140,000 138,856 10,800 12,277 20,407 1,539 Note Payable – Other In November 2016, the Company secured a $ 50,000 4 1,000,000 During the years ended June 30, 2023 and 2022, the Company recorded interest expense of $ 2,000 2,000 13,282 11,282 Convertible note payable – BENZA, D2CF On March 1, 2016 and March 3, 2016, the Company closed a private placement of debt and received an aggregate of $ 612,500 13,750 660,000 On July 21, 2023, the Company entered into settlement agreements with the principals of the company. In the Nevada Lawsuit (see Note 10), the Company agreed to settle for $345,000, with $145,000 paid upon signing and $200,000 due within 6 months. The Settlement Agreement allows for an increased payment of $600,000 if the Second Nevada Settlement Payment isn’t made within six months. In the New York Lawsuit (see Note 10), the Company will pay $80,000, with $10,000 due upon execution of the Settlement. Payments received by the Company will be applied first to the Second New York Payment. As of June 30, 2023 and 2022, the Company reported $ 673,750 673,750 Convertible note payable - Leonite Capital, LLC 2022 Note On December 5, 2022, the Company received $ 250,000 on issuing the first tranche of $ 1,000,000 senior secured convertible note (“Leonite 2022 Convertible Note”) from Leonite, net of an original issue discount of $ 62,500 . The term of the convertible note is fifteen months from the date of closing and matures on March 5, 2024 . The Company is required to only pay interest expense on a monthly basis for the first six months of the term. During the year ended June 30, 2023, the Company accrued $ 19,482 of interest expense related to the convertible notes. As of June 30, 2023, the company reported $246,148 as Convertible notes – Leonite payable. The Company will begin making nine equal amortization payments of $ 34,722 15,000,000 78,000 28,064 10,000 59,936 27,455 28,629 10 0.007 2019 Note On November 19, 2019, the Company, together with Hypersoft Ventures (collectively, the “Borrower”), received $ 135,000 150,000 15,000 250,000 2,700,000 260,000 The Company has determined that the conversion feature embedded in the Leonite Convertible Note constitutes a derivative and has been bifurcated from the Leonite Convertible Note and recorded as a derivative liability, with a corresponding discount recorded to the associated debt, on the accompanying balance sheet, and revalued to fair market value at each reporting period. The initial issuance yielded a derivative liability of $94,225, with a discount of $150,000 to be amortized over the 9-month life of the Leonite Convertible Note. Significant assumptions used in calculating fair value of conversion feature of Leonite Convertible Note at issuance date are as follows. Schedule of assumptions Expected Dividends Expected volatility Risk-free rate of interest Expected term (year) Exercise (Conversion) price Common stock price per share 0.00% 809.71% 0.0154% 0.75 $ 0.02 $ 0.01300 On June 4, 2021, the Company and Leonite renegotiated the convertible note for two years, face value of $260,000. At June 30, 2021, the Company recorded $281,845 in derivative liabilities. On July 29, 2021, Leonite converted $ 42,750 2,250 15,000,000 44,475 2,250 10,269,253 On October 6, 2021, Leonite converted $ 57,952 2,250 13,231,209 125,000 2,250 27,917,969 96,145 Schedule of extinguishment of debt Balance at June 30, 2021 $ 260,000 Accrued interest 9,954 Leonite Convertible Note converted (269,954 ) Total – Less: debt discount – Balance at June 30, 2022 $ – The resulting derivative valuation is calculated as follows: Schedule of derivative liabilities at fair value Derivative as of June 30, 2021 $ 281,845 Change in fair value 213,053 494,898 Write off due to conversions (398,753 ) 96,145 Gain on extinguishment (96,145 ) Derivative as of June 30, 2022 $ – Significant assumptions used in calculating fair value of conversion feature of Leonite convertible Note as of June 30, 2022 are as follows. Schedule of assumptions Expected Dividends Expected volatility Risk-free rate of interest Expected term (year) Exercise (Conversion) price Common stock price per share 0.00% 269.75% 0.0007% 1.9288 $ 0.00550 $ 0.010 Credit line – MediPendant New York Inc. On September 30, 2014, the subsidiary received a line of credit with Medi Pendant New York, Inc. (“MNY). Under the original terms of the line of credit agreement, the Company was able to borrow up to $ 300,000 6.5 September 30, 2017 500,000 200,000 25,653 8,436 397,500 397,500 Debt settlement – On Deck, Susquehanna, MCA Cure In 2019, our subsidiary engaged MCA CURE to negotiate settlements with two creditors: On Deck and Susquehanna Salt, noted in the table above. The Company ceased paying the loan payments and paid to MCA Cure $ 43,875 47,000 90,875 0 0 139,569 139,569 0 10,500

Shareholders_ Deficit

Shareholders’ Deficit	12 Months Ended
	Jun. 30, 2023
Equity [Abstract]
Shareholders’ Deficit	Note 8 – Shareholders’ Deficit Preferred Stock: The Company is currently authorized to issue 25,000,000 0.0001 Series A Convertible Preferred Stock 0.0001 Series B Convertible Preferred Stock 0.0001 Series C Convertible Preferred Stock 0.0001 The Company issued 6,700,003 shares for the BOAPIN asset purchase; these shares were issued on September 1, 2020. As of June 30, 2023 and 2022, 6,838,889 shares of Series C Convertible Preferred Stock were issued and outstanding, respectively. Series D Convertible Preferred Stock : 0.0001 Series E Convertible Preferred Stock : 0.0001 As of June 30, 2023 and 2022, 4,000,000 Common Stock The Company is currently authorized to issue 3,000,000,000 0.0001 During the year ended June 30, 2022, the Company · issued a total of 409,650,000 shares of common stock for a total value of $6,556,845 resulting in an average price of $0.016 per share, · issued 66,418,431 for $260,000 in debt, $9,954 in interest, and $9,000 in fees, valued at $677,707, which represents the fair value of shares issued, · issued 10,000,000 shares of common stock for services, valued at $48,300 or $0.0161 per share, · sold 360,000,000 shares of common stock to unaffiliated individuals and groups at $0.01 under the Reg A filing, of which 10,000,000 are yet to be issued, · accrued 7,262,500 shares of common stock for officer’s compensation and bonuses, valued at $104,126 or $0.0143 shares, and · accrued 6,840,000 shares of common stock for employee compensation and bonuses, valued at $88,551 or $0.0129 shares. All shares were recorded at the stock price of the date of agreement or grant. During the year ended June 30, 2023, the Company · issued 9,612,500 124,108 · issued 7,000,000 90,000 · issued 36,500,000 309,481 · issued 20,000,000 164,000 All shares were recorded at the stock price of the date of agreement or grant. During the year ended June 30, 2023, the Company also recorded shares to be issued of 13,899,999 93,660 65,000 651 During the year ended June 30, 2023, the Company received proceeds totaling $ 739,500 170,262,500 325,000 37,812,500 304,500 30,450,000 10,000 2,000,000 100,000 100,000,000 As of June 30, 2023 and 2022, the Company had 1,566,255,108 1,493,142,608

Related Party Transactions

Related Party Transactions	12 Months Ended
	Jun. 30, 2023
Related Party Transactions [Abstract]
Related Party Transactions	Note 9 – Related Party Transactions Note payable – BOAPIN purchase In August 2020, and effective as of June 30, 2020, the Company purchased the BOAPIN portal, including all software, licensing, and ownership rights from Hypersoft Ventures, Inc., a related party through common ownership, for $800,200, which includes six million seven hundred thousand three (6,700,003) shares of Series C Convertible Preferred stock, valued at $375,200 or $0.056 per share, based on the conversion of one share of Series C Preferred stock for 10 shares of common stock and the stock price on the date of the transaction, and a note payable for $425,000, bearing twelve percent (12%) interest with no prepayment or delinquency clauses. As of June 30, 2023 and 2022, the Company recorded Note payable-BOAPIN of $ 170,000 170,000 13,600 21,900 63,015 49,415 Related party debt From time to time, the Company received funds from related parties for day-to-day operations. These are short-term loans which bear no interest, and the Company expects to repay these loans by the end of the fiscal year following the year in which the short-term loan was made. At June 30, 2022, the Company had a receivable from certain management employees totaling $155,800. The total receivable balance was subsequently collected by the Company on September 27, 2022. Schedule of related party transactions 2023 2022 Related parties – subsidiary $ 177,320 $ 202,875 Due from related parties – (155,800 ) Accrued salaries, bonus, fees 621,812 166,765 Total loans from related parties, net $ 799,132 $ 58,040 Settlement agreement with former officer On May 10, 2023, the Company entered into a severance and settlement agreement with Jennifer Loria, the Company’s former Chief Operating Officer of its wholly-owned subsidiary Medical Alarm Concepts LLC. The severance and settlement agreement includes payments totaling $ 35,000 5,000 15,000 15,000 5,000 14,000

Commitments and contingencies

Commitments and contingencies	12 Months Ended
	Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and contingencies	Note 10 – Commitments and contingencies Legal Matters From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. 1) Legal Proceedings Involving Aqualaro Corp On October 24, 2022, Aqualaro Corp. filed a lawsuit against the Company and its transfer agent in the Supreme Court of the State of New York, County of New York. Aqualaro sought monetary damages and an injunction to transfer 56 million shares of common stock to an individual. An amended complaint was filed on October 26, 2022. On December 5, 2022, the Company moved to dismiss the amended complaint. On April 13, 2023, the Court granted the Company’s motion but allowed the plaintiff to refile. On April 26, 2023, a second amended complaint was filed against the Company, adding Mr. Pizzino as a defendant. On May 8, 2023, Acqualaro filed a notice of appeal regarding the decision to dismiss the first amended complaint. On August 3, 2023, Aqualaro filed a third amended complaint. On August 14, 2023, the Company moved to dismiss the Third Amended Complaint. 2) Settlement Agreements on July 21, 2023 The Company entered into a Settlement Agreement related to two litigations: - Benza Pharma, LLC, et al. v. Wearable Health Solutions, Inc., et al. in Clark County Nevada. - GRQ Consultants, Inc. v. Wearable Health Solutions Inc. in the Supreme Court of the State of New York. In the Nevada Lawsuit, the Company agreed to settle for $345,000, with $145,000 paid upon signing and $200,000 due within 6 months. The Settlement Agreement allows for an increased payment of $600,000 if the Second Nevada Settlement Payment isn’t made within six months. In the New York Lawsuit, the Company will pay $80,000, with $10,000 due upon execution of the Settlement. Payments received by the Company will be applied first to the Second New York Payment. 3) Medical Alarm Concepts LLC v. MCA Cure, LLC The Company sought the return of payments for non-performance, attorney fees, and court costs. An initial settlement was reached where MCA Cure would pay $10,000 upfront and $6,500 monthly until the debt was paid off in 2023. The defendants breached the settlement agreement, leading to a reopened case. A judgment of $148,875.00, including punitive damages for fraud, was entered against all three defendants on August 25th. Pre-judgment interest of $1,066.60 and costs were also awarded to the plaintiffs. Other than the aforementioned, we are not presently a party to any legal proceedings that, in the opinion of our management, are likely to have a material adverse effect on our business. Regardless of outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors. Commitments and Contingencies. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows. Office lease In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which supersedes the current accounting for leases and while retaining two distinct types of leases, finance and operating, (1) requires lessees to record a right of use asset and a related liability for the rights and obligations associated with a lease, regardless of lease classification, and recognize lease expense in a manner similar to current accounting, (2) eliminates most real estate specific lease provisions, and (3) aligns many of the underlying lessor model principles with those in the new revenue standard. Leases with a term of 12 months or less will be accounted for similar to existing guidance for operating leases today. For public companies, the new standard is effective for annual and interim periods in fiscal years beginning after December 15, 2018. For all other entities, including emerging growth companies, this standard is effective for annual reporting periods beginning after December 15, 2019, and interim periods within fiscal years beginning after December 2020. The Company maintains its corporate office at 2901 W. Coast Highway, Suite 200, Newport Beach, CA 92663. The Company currently pays $175 a month for its office space and the term is month-to-month. The Company’s subsidiary maintained a warehouse office in Pennsylvania to facilitate inventory arrival and product shipment. The three-year lease at $1,100 per month expired on September 30, 2021, and was renewed for 12 months at $1,300 per month beginning October 1, 2021 and expiring on September 30, 2022. The subsidiary subsequently entered into a month-to-month arrangement with this office warehouse and then terminated the arrangement and vacated the facility as of December 31, 2022. The Company entered into a new three-year lease agreement on September 9, 2022 for new warehouse space located in Mequon, Wisconsin. The monthly rent for this new warehouse space is currently $ 1,325 Schedule of office lease expenditures 2023 2022 Rent expense $ 20,350 $ 16,605 The Company leased a fulfillment center in the U.S., which was classified as an operating lease which subsequently expired on September 30, 2022. The Company determines if an arrangement qualifies as a lease at the lease inception. Operating lease liabilities are recorded based on the present value of the future lease payments over the lease term, assessed as of the commencement date. The Company’s real estate leases, which are for a fulfillment center, generally have a lease term between 3 and 5 years. The Company’s leases are comprised of fixed lease payments and also include executory costs such as common area maintenance, as well as property insurance and property taxes. The Company has elected to account for the lease and non-lease components as a single lease component for its real estate leases. Lease payments, which may include lease components and non-lease components, are included in the measurement of the Company’s lease liabilities to the extent that such payments are either fixed amounts or variable amounts based on a rate or index (fixed in substance) as stipulated in the lease contract. Any actual costs in excess of such amounts are expensed as incurred as variable lease cost. The Company’s lease agreements generally do not specify an implicit borrowing rate, and as such, the Company utilizes its incremental borrowing rate by lease term, in order to calculate the present value of the future lease payments. The discount rate represents a risk-adjusted rate on a secured basis, and is the rate at which the Company would borrow funds to satisfy the scheduled lease liability payment streams commensurate with the lease term. The Company’s lease agreement for its warehouse space located in King of Prussia, Pennsylvania expired on September 30, 2022. The Company has terminated the month-to-month arrangement and has vacated the warehouse located in King of Prussia, Pennsylvania as of December 31, 2022. As a result, the Company entered into a new three-year lease agreement on September 9, 2022 for new warehouse space located in Mequon, Wisconsin. The monthly rent which commenced in September 2022 is $ 1,325 3 43,058 Certain of the Company’s lease agreements, primarily related to real estate, include options for the Company to either renew (extend) or early terminate the lease. Leases with renewal options allow the Company to extend the lease term typically between 1 3 For the year ended June 30, 2023, total operating lease cost was $ 16,270 Schedule of future minimum undiscounted lease payments Fiscal Year Ending June 30, 2024 $ 16,250 2025 16,670 July & August 2025 2,790 Total future minimum lease payments 35,710 Less imputed interest (3,203 ) Total present value of future minimum lease payments $ 32,507 As of June 30, 2023 Operating lease right-of-use assets $ 32,157 Accrued lease liability 14,039 Long-term lease liability 18,468 $ 32,507 As of June 30, 2023 Weighted Average Remaining Lease Term 2.17 Weighted Average Discount Rate 8.44

Other Income - Settlement

Other Income - Settlement	12 Months Ended
	Jun. 30, 2023
Other Income and Expenses [Abstract]
Other Income - Settlement	Note 11 – Other Income - Settlement Settlement In 2019, the Company engaged MCA Cure to negotiate settlements with two note holders, and paid MCA Cure a total of $ 97,625 105,125 As of June 30, 2023 and 2022, the Company has recorded $ 19,500 36,000

Income Taxes

Income Taxes	12 Months Ended
	Jun. 30, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Note 12 – Income Taxes Deferred income tax assets and liabilities are computed annually for differences between financial statement and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities. The effective tax rate on the net loss before income taxes differs from the U.S. statutory rate as follows: Schedule of effective tax rate June 30, 2023 June 30, 2022 U.S. statutory rate 21.00 21.00 PA state corporate tax 9.99 9.99 Less valuation allowance (30.99 ) (30.99 ) Effective tax rate 0 0 The significant components of deferred tax assets and liabilities are as follows, expiring in 2024 and 2025, on net operating losses of $ 41,517,489 39,423,382 Schedule of deferred tax asset and liabilities 2023 2022 Net deferred tax assets $ 12,866,270 $ 12,217,306 Less valuation allowance (12,866,270 ) (12,217,306 ) Deferred tax asset - net valuation allowance $ 0 $ 0 The valuation allowance increased by $648,964 for the year ended June 30, 2023. Uncertain Tax Positions.

Subsequent Events

Subsequent Events	12 Months Ended
	Jun. 30, 2023
Subsequent Events [Abstract]
Subsequent Events	Note 13 – Subsequent Events The Company evaluated events that have occurred after the balance sheet date but before the consolidated financial statements are issued and determined that there are no material events that are required to be disclosed. On July 27, 2023, Mr. Vincent Miceli resigned his employment in the capacity of CFO for the Company. On October 4, 2023, Mr. Miceli filed a breach of contact complaint in the state of Connecticut against the Company. On July 27, 2023, Mr. Eric Sherb, CPA was appointed as the Company interim CFO. Through October 20, 2023, the Company has issued 125,000,000 common shares pursuant to its Regulation A offering for net proceeds of $99,000. Through October 20, 2023, the Company issued 112,600,000 common shares pursuant to subscriptions received prior to June 30, 2023, however the shares had not yet been issued as of June 30, 2023. As of October 20, 2023, the Company has 1,804,355,108 common shares issued and outstanding.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation
Principles of Consolidation	Principles of Consolidation
Use of Estimates	Use of Estimates
Cash and Cash Equivalents	Cash and Cash Equivalents
Accounts Receivable	Accounts Receivable 379 0 23,705 0
Concentration of Credit Risk	Concentration of Credit Risk
Recognition of Revenues	Recognition of Revenues The Company’s revenues are derived principally from utilizing new technology in the medical alarm industry to provide 24-hour personal response monitoring services and related products to subscribers with medical- or age-related conditions. The Company recognizes revenue when it is realized or realizable and earned. For hardware sales, the Company recognizes revenues when the product is shipped. Customers are billed on Net 30 terms. For service revenue, the Company recognizes revenues when the time period for service is current. For customers who pay several months at a time, the Company records revenues for the month’s services and the balance of funds to deferred revenues, and records the balance of revenues as they become current. Schedule of revenues REVENUES 2023 2022 Hardware revenue $ 219,049 $ 134,045 Service revenue 526,044 911,845 TOTAL REVENUES $ 745,093 $ 1,045,890
Deferred Taxes	Deferred Taxes ASC 740, Income Taxes, requires a company to first determine whether it is more likely than not (which is defined as a likelihood of more than fifty percent) that a tax position will be sustained based on its technical merits as of the reporting date, assuming that taxing authorities will examine the position and have full knowledge of all relevant information. A tax position that meets this more-likely-than-not threshold is then measured and recognized at the largest amount of benefit that is greater than fifty percent likely to be realized upon effective settlement with a taxing authority. The Federal and state income tax returns of the Company for 2023, 2022 and 2021 are subject to examination by the Internal Revenue Service and state taxing authorities for three (3) years from the date filed.
Related party transactions	Related party transactions a. Affiliates of the Company; b. Entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c. Trusts for the benefit of employees, such as pension and profit sharing trusts that are managed by or under the trusteeship of management; d. Principal owners of the Company; e. Management of the Company; f. Other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g. Other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests. The financial statements include disclosures of material related party transactions, other than compensation arrangements, expense allowances and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of financial statements is not required in those statements. The disclosures shall include: a. The nature of the relationship involved; b. A description of the transactions, including transactions to which no amounts or nominal amounts were ascribed for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c. The dollar amount of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d. Amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.
Fair value of financial instruments	Fair value of financial instruments Level 1 Level 2 Level 3 From time to time, our financial instruments include cash, accounts payable and accrued expenses, convertible notes, lines of credit, and credit cards. Property and Equipment, Net When assets are retired or otherwise disposed of, the cost, accumulated depreciation and amortization are removed from the accounts and any resulting gain or loss is reflected in the consolidated statements of operations in the period realized. Maintenance and repairs that do not enhance or extend the asset’s useful life are charged to operating expenses as incurred. Impairment of Long-Lived Assets. The impairment test for identifiable indefinite-lived intangible assets consists of a comparison of the estimated fair value of the intangible asset with its carrying value. If the carrying value exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. The Company did not record any impairment losses on its long-lived assets as of June 30, 2023 or 2022.
Software Development for internal use	Software Development for internal use
Research and Development	Research and Development - 49,680 390,828
Basic and Diluted Loss per Common Share	Basic and Diluted Loss per Common Share Schedule of anti-dilutive shares Basis of conversion Dilution 2023 2022 Series A Convertible 688 shares outstanding 1 share A: 2 shares 1,376 1,376 Series B Convertible 9,938 shares outstanding 1 share B: 2 shares 19,876 19,876 Series C Convertible 6,838,889 shares outstanding 1 share C: 10 shares 68,388,890 68,388,890 Series D Convertible 425,000 shares outstanding 1 share D: 10 shares 4,250,000 4,250,000 Series E Convertible 4,000,000 shares outstanding 1 share E: 100 shares 400,000,000 400,000,000 472,660,142 472,660,142 Because the Company incurred losses for the past two years, the basic and diluted share bases will be presented as the same. For the years ended June 30, 2023 and 2022, the Company incurred losses of ($0.00156) and ($0.01202) per basic share and diluted share, respectively.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In August 2020, the FASB issued ASU No. 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (ASU 2020-06), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity’s own equity. Among other changes, ASU 2020-06 removes from U.S. GAAP the liability and equity separation model for convertible instruments with a cash conversion feature, and as a result, after adoption, entities will no longer separately present in equity an embedded conversion feature for such debt. Similarly, the embedded conversion feature will no longer be amortized into income as interest expense over the life of the instrument. Instead, entities will account for a convertible debt instrument wholly as debt unless (1) a convertible instrument contains features that require bifurcation as a derivative under ASC Topic 815, Derivatives and Hedging, or (2) a convertible debt instrument was issued at a substantial premium. Among other potential impacts, this change is expected to reduce reported interest expense, increase reported net income, and result in a reclassification of certain conversion feature balance sheet amounts from shareholders’ equity to liabilities as it relates to the Company’s convertible senior notes. Additionally, ASU 2020-06 requires the application of the if-converted method to calculate the impact of convertible instruments on diluted earnings per share (EPS), which is consistent with the Company’s accounting treatment under the current standard. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, with early adoption permitted for fiscal years beginning after December 15, 2020, and can be adopted on either a fully retrospective or modified retrospective basis. The Company early adopted the ASU on July 1, 2022, the beginning of its fiscal year. The Company does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the consolidated financial position, statements of operations and cash flows.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Schedule of revenues	Schedule of revenues REVENUES 2023 2022 Hardware revenue $ 219,049 $ 134,045 Service revenue 526,044 911,845 TOTAL REVENUES $ 745,093 $ 1,045,890
Schedule of anti-dilutive shares	Schedule of anti-dilutive shares Basis of conversion Dilution 2023 2022 Series A Convertible 688 shares outstanding 1 share A: 2 shares 1,376 1,376 Series B Convertible 9,938 shares outstanding 1 share B: 2 shares 19,876 19,876 Series C Convertible 6,838,889 shares outstanding 1 share C: 10 shares 68,388,890 68,388,890 Series D Convertible 425,000 shares outstanding 1 share D: 10 shares 4,250,000 4,250,000 Series E Convertible 4,000,000 shares outstanding 1 share E: 100 shares 400,000,000 400,000,000 472,660,142 472,660,142

Inventory, Prepaid Inventory _2

Inventory, Prepaid Inventory and Prepaid Expenses (Tables)	12 Months Ended
	Jun. 30, 2023
Inventory Disclosure [Abstract]
Schedule of prepaid expenses	Schedule of prepaid expenses 2023 2022 Inventory $ 8,555 $ 7,064 2023 2022 Prepaid inventory $ 7,242 $ 62,040

Property and Equipment (Tables)

Property and Equipment (Tables)	12 Months Ended
	Jun. 30, 2023
Property, Plant and Equipment [Abstract]
Schedule of property, plant and equipment	Schedule of property, plant and equipment 2023 2022 Furniture $ 20,000 $ 20,000 Office computers, equipment, software 19,689 19,689 Software development costs 45,900 45,900 Dealer portal 50,000 50,000 Furniture 9,443 – Property, plant, and equipment 145,032 135,589 Less accumulated depreciation (106,343 ) (93,938 ) Net property, plant, and equipment $ 38,689 $ 41,651 Depreciation expense was $12,404 and $8,349 for the year ended June 30, 2023 and 2022 respectively.

Notes Payable and Notes Payab_2

Notes Payable and Notes Payable - Other (Tables)	12 Months Ended
	Jun. 30, 2023
Debt Instrument [Line Items]
Schedule of short term notes payable	Schedule of short term notes payable June 30, 2023 2022 Notes from subsidiary $ 158,333 $ 174,243 Notes payable - Reg A deposits 140,000 138,856 Short term bridge loan 100,000 100,000 Total Notes Payable $ 398,333 $ 413,099 Notes Payable - Subsidiary The Company has various loans and credit lines outstanding. The credit line carries an interest rate of 6.24 9.24 10.90
Schedule of notes payable	Schedule of notes payable 2023 2022 Wells Fargo Loan $ 8,770 $ 8,770 On Deck Loan 139,569 139,569 Susquehanna Salt Loan – 10,500 Prosper Loans 9,994 9,994 Marcus Loan – 5,410 Notes payable - subsidiary $ 158,333 $ 174,243
Schedule of assumptions	Schedule of assumptions Expected Dividends Expected volatility Risk-free rate of interest Expected term (year) Exercise (Conversion) price Common stock price per share 0.00% 269.75% 0.0007% 1.9288 $ 0.00550 $ 0.010
Schedule of extinguishment of debt	Schedule of extinguishment of debt Balance at June 30, 2021 $ 260,000 Accrued interest 9,954 Leonite Convertible Note converted (269,954 ) Total – Less: debt discount – Balance at June 30, 2022 $ –
Schedule of derivative liabilities at fair value	Schedule of derivative liabilities at fair value Derivative as of June 30, 2021 $ 281,845 Change in fair value 213,053 494,898 Write off due to conversions (398,753 ) 96,145 Gain on extinguishment (96,145 ) Derivative as of June 30, 2022 $ –
Leonite Convertible Note November 2019 [Member]
Debt Instrument [Line Items]
Schedule of assumptions	Schedule of assumptions Expected Dividends Expected volatility Risk-free rate of interest Expected term (year) Exercise (Conversion) price Common stock price per share 0.00% 809.71% 0.0154% 0.75 $ 0.02 $ 0.01300

Related Party Transactions (Tab

Related Party Transactions (Tables)	12 Months Ended
	Jun. 30, 2023
Related Party Transactions [Abstract]
Schedule of related party transactions	Schedule of related party transactions 2023 2022 Related parties – subsidiary $ 177,320 $ 202,875 Due from related parties – (155,800 ) Accrued salaries, bonus, fees 621,812 166,765 Total loans from related parties, net $ 799,132 $ 58,040

Commitments and contingencies (

Commitments and contingencies (Tables)	12 Months Ended
	Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Schedule of office lease expenditures	Schedule of office lease expenditures 2023 2022 Rent expense $ 20,350 $ 16,605
Schedule of future minimum undiscounted lease payments	Schedule of future minimum undiscounted lease payments Fiscal Year Ending June 30, 2024 $ 16,250 2025 16,670 July & August 2025 2,790 Total future minimum lease payments 35,710 Less imputed interest (3,203 ) Total present value of future minimum lease payments $ 32,507 As of June 30, 2023 Operating lease right-of-use assets $ 32,157 Accrued lease liability 14,039 Long-term lease liability 18,468 $ 32,507 As of June 30, 2023 Weighted Average Remaining Lease Term 2.17 Weighted Average Discount Rate 8.44

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Jun. 30, 2023
Income Tax Disclosure [Abstract]
Schedule of effective tax rate	Schedule of effective tax rate June 30, 2023 June 30, 2022 U.S. statutory rate 21.00 21.00 PA state corporate tax 9.99 9.99 Less valuation allowance (30.99 ) (30.99 ) Effective tax rate 0 0
Schedule of deferred tax asset and liabilities	Schedule of deferred tax asset and liabilities 2023 2022 Net deferred tax assets $ 12,866,270 $ 12,217,306 Less valuation allowance (12,866,270 ) (12,217,306 ) Deferred tax asset - net valuation allowance $ 0 $ 0

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details - Schedule of Revenues) - USD ($)	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Product Information [Line Items]
Total Revenues	$ 745,093	$ 1,045,890
Hardware Revenue [Member]
Product Information [Line Items]
Total Revenues	219,049	134,045
Service Revenue [Member]
Product Information [Line Items]
Total Revenues	$ 526,044	$ 911,845

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details - Antidilutive information) - shares	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
AntiDilutive Shares	472,660,142	472,660,142
Series A Preferred Stock [Member]
AntiDilutive Shares	1,376	1,376
Series B Preferred Stock [Member]
AntiDilutive Shares	19,876	19,876
Series C Preferred Stock [Member]
AntiDilutive Shares	68,388,890	68,388,890
Series D Preferred Stock [Member]
AntiDilutive Shares	4,250,000	4,250,000
Series E Preferred Stock [Member]
AntiDilutive Shares	400,000,000	400,000,000
Series A Convertible Stock [Member]
Basis of conversion	688 shares outstanding
Dilution	1 share A: 2 shares
Series B Convertible Stock [Member]
Basis of conversion	9,938 shares outstanding
Dilution	1 share B: 2 shares
Series C Convertible Stock [Member]
Basis of conversion	6,838,889 shares outstanding
Dilution	1 share C: 10 shares
Series D Convertible Stock [Member]
Basis of conversion	425,000 shares outstanding
Dilution	1 share D: 10 shares
Series E Convertible Stock [Member]
Basis of conversion	4,000,000 shares outstanding
Dilution	1 share E: 100 shares

Summary of Significant Accoun_6

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Accounting Policies [Abstract]
Accounts receivable, net	$ 379	$ 0
Allowance for doubtful accounts	23,705	0
Other Research and Development Expense	$ 49,680	$ 390,828

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accumulated deficit	$ 41,811,849	$ 39,423,382
Net cash used in operating activities	1,279,472	3,107,177
Stock compensation non-cash expenses	294,360	10,044,522
Net loss	2,388,467	13,049,155
Cash flow from financing activities	1,354,560	$ 2,380,252
Working capital	$ 3,379,991

Inventory, Prepaid Inventory _3

Inventory, Prepaid Inventory and Prepaid Expenses (Details - Schedule of inventory) - USD ($)	Jun. 30, 2023	Jun. 30, 2022
Inventory Disclosure [Abstract]
Inventory	$ 8,555	$ 7,064
Prepaid inventory	$ 7,242	$ 62,040

Property and Equipment (Details

Property and Equipment (Details) - USD ($)	Jun. 30, 2023	Jun. 30, 2022
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 145,032	$ 135,589
Less accumulated depreciation	(106,343)	(93,938)
Net property, plant, and equipment	38,689	41,651
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	20,000	20,000
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	19,689	19,689
Software Development [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	45,900	45,900
Dealer Portal [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	50,000	50,000
Office Furniture [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 9,443	$ 0

Property and Equipment (Detai_2

Property and Equipment (Details Narrative) - USD ($)	Sep. 26, 2022	Aug. 30, 2021	Jun. 30, 2023	Jun. 30, 2022
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross			$ 145,032	$ 135,589
Property, Plant and Equipment, Other, Net			38,689	41,651
Dealer Portal [Member]
Property, Plant and Equipment [Line Items]
Purchase of equipments		$ 50,000
Purchase of equipment life		60 months
Office Furniture [Member]
Property, Plant and Equipment [Line Items]
Purchase of equipments	$ 9,442
Used Furniture [Member]
Property, Plant and Equipment [Line Items]
Purchase of equipment life	36 months
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross			20,000	20,000
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross			19,689	19,689
Software Development [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross			$ 45,900	$ 45,900

Accounts Payable and Accrued _2

Accounts Payable and Accrued Expenses and liabilities (Details Narrative) - USD ($)	Jun. 30, 2023	Jun. 30, 2022
Payables and Accruals [Abstract]
Accounts payable	$ 162,936	$ 57,940
Accrued expenses and other current liabilities	$ 517,067	$ 374,278

Notes Payable and Note payable-

Notes Payable and Note payable-other (Details - Schedule of short term notes) - USD ($)	Jun. 30, 2023	Jun. 30, 2022
Debt Disclosure [Abstract]
Notes from subsidiary	$ 158,333	$ 174,243
Notes payable - Reg A deposits	140,000	138,856
Short term bridge loan	100,000	100,000
Total Notes Payable	$ 398,333	$ 413,099

Notes Payable and Note payabl_2

Notes Payable and Note payable-other (Details - Notes payable) - USD ($)	Jun. 30, 2023	Jun. 30, 2022
Debt Instrument [Line Items]
Notes Payable	$ 158,333	$ 174,243
Wells Fargo Loan [Member]
Debt Instrument [Line Items]
Notes Payable	8,770	8,770
On Deck Loan [Member]
Debt Instrument [Line Items]
Notes Payable	139,569	139,569
Susquehanna Salt Loan [Member]
Debt Instrument [Line Items]
Notes Payable	0	10,500
Prosper Loans [Member]
Debt Instrument [Line Items]
Notes Payable	9,994	9,994
MARCUS Loan [Member]
Debt Instrument [Line Items]
Notes Payable	$ 0	$ 5,410

Notes Payable and Note Payable

Notes Payable and Note Payable - Other (Details - Notes payable) - $ / shares	Jun. 30, 2022	Nov. 19, 2019
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Share Price	$ 0.010	$ 0.01300
Measurement Input, Expected Dividend Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivatives, determination of fair value	0.00%	0.00%
Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivatives, determination of fair value	269.75%	809.71%
Measurement Input, Risk Free Interest Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivatives, determination of fair value	0.0007%	0.0154%
Measurement Input, Expected Term [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivatives, determination of fair value	1.9288	0.75
Measurement Input, Exercise Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivatives, determination of fair value	0.00550	0.02

Notes Payable and Note Payabl_3

Notes Payable and Note Payable - Other (Details - Schedule of Extinguishment of Debt) - USD ($)	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Debt Instrument [Line Items]
Convertible debt issued	$ 240,000	$ 25,000
Leonite Capital [Member]
Debt Instrument [Line Items]
Convertible debt, beginning balance	$ 0	260,000
Convertible debt issued		9,954
Convertible debt converted		(269,954)
Convertible debt, beginning balance		0
Debt discount		0
Convertible debt, ending balance		$ 0

Notes Payable and Note Payabl_4

Notes Payable and Note Payable - Other (Details - Derivative Liabilities) - USD ($)	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Debt Disclosure [Abstract]
Derivative liabilities, Beginning	$ 0	$ 281,845
Change in fair value		213,053
Total Fair Value Derivative Liabilities		494,898
Write off due to conversions		(398,753)
Total fair value of derivative		96,145
Gain on extinguishment	$ 0	(96,145)
Derivative liabilities, Ending		$ 0

Notes Payable and Notes Payab_3

Notes Payable and Notes Payable - Other (Details Narrative) - USD ($)								1 Months Ended				12 Months Ended
	May 10, 2023	Dec. 05, 2022	Oct. 26, 2021	Oct. 06, 2021	Aug. 27, 2021	Jul. 29, 2021	Nov. 19, 2019	Nov. 30, 2021	Nov. 30, 2016	Jan. 31, 2015	Sep. 30, 2014	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2020	Jun. 30, 2019	Aug. 19, 2021	Jun. 30, 2021	Jun. 04, 2021	Sep. 30, 2020	Jul. 31, 2020	Jun. 30, 2016	Mar. 03, 2016	Mar. 01, 2016	Jun. 30, 2015
Debt Instrument [Line Items]
Rate of interest												6.24%
Short term note payables												$ 100,000	$ 100,000				$ 500,000
Accrued interest												12,000	21,649				$ 55,027
Repayment of principal amount																$ 300,000
Repayment of debt								$ 100,000
Accrued interest payable												88,677	76,677
Interest expense												10,800	12,277
Other notes payable												140,000	138,856
Acquisition of convertible notes payable									$ 1,000,000
Accrued interest payable												63,015	49,415
Company received amount												240,000	25,000
Number of value issued other													3,399,999
Legal fees	$ 15,000
Amortized deferred debt issuance costs												27,455	0
Unsecured convertible							$ 250,000
Gain on debt extinguishment												0	96,145
Borrowed amount											$ 300,000
Accrued Interest																					$ 25,653			$ 8,436
Line of credit balance												397,500	397,500
Notes payable												158,333	174,243
MCA Cure [Member]
Debt Instrument [Line Items]
Loan payments														$ 47,000	$ 43,875
Reserve fund																			$ 90,875
Medi Pendant New York Inc [Member]
Debt Instrument [Line Items]
Rate of interest											6.50%
Maturity date											Sep. 30, 2017
Increased amount										$ 500,000
Issuance of shares										200,000
Notes Payable, Other Payables [Member]
Debt Instrument [Line Items]
Accrued interest payable												13,282	11,282
B2CF [Member]
Debt Instrument [Line Items]
Convertible notes																						$ 13,750	$ 13,750
BENZA [Member]
Debt Instrument [Line Items]
Convertible notes																						660,000	660,000
BENZA and D2CF [Member]
Debt Instrument [Line Items]
Convertible notes												$ 673,750	673,750
Leonite Convertible Note [Member]
Debt Instrument [Line Items]
Interest rate												10%
Interest expense												$ 19,482
Company received amount		$ 250,000					135,000
Convertible note face value		1,000,000					150,000											$ 260,000
Original Issue Discount		$ 62,500					$ 15,000
Maturity date		Mar. 05, 2024
Amortization payments												$ 34,722
Number of shares issued other												15,000,000
Number of value issued other												$ 78,000
Common stocks to be issued												28,064
Legal fees												10,000
Deferred debt issuance costs												59,936
Amortized deferred debt issuance costs												27,455
Amortized original issue discount												$ 28,629
Conversion price												$ 0.007
Stock issued for debt shares							2,700,000
MCA Cure [Member]
Debt Instrument [Line Items]
Notes payable												$ 0	0
On Deck Loan [Member]
Debt Instrument [Line Items]
Notes payable												139,569	139,569
Susquehanna Salt Loan [Member]
Debt Instrument [Line Items]
Notes payable												0	10,500
Notes Payable, Other Payables [Member]
Debt Instrument [Line Items]
Interest expense												2,000	2,000
Party Related to Former CEO [Member]
Debt Instrument [Line Items]
Other notes payable									$ 50,000
Debt instrument percentage									4%
Leonite [Member]
Debt Instrument [Line Items]
Debt Instrument, Convertible, Liquidation Preference, Value			$ 125,000	$ 57,952	$ 44,475	$ 42,750
Debt Instrument, Fee Amount			$ 2,250	$ 2,250	$ 2,250	$ 2,250
Debt Conversion, Converted Instrument, Shares Issued			27,917,969	13,231,209	10,269,253	15,000,000
Gain on debt extinguishment			$ 96,145
Regulation A Filing [Member]
Debt Instrument [Line Items]
Accrued interest payable												20,407	1,539
Regulation A Filing [Member] | Two Unaffiliated Investors [Member]
Debt Instrument [Line Items]
Accepted stock payment												$ 140,000	$ 138,856
Private Placement [Member]
Debt Instrument [Line Items]
Aggregate amount																						$ 612,500	$ 612,500
COHEN [Member]
Debt Instrument [Line Items]
Short term bridge loan																				$ 500,000
Accrued interest rate																				12%
Minimum [Member]
Debt Instrument [Line Items]
Interest rate												9.24%
Maximum [Member]
Debt Instrument [Line Items]
Interest rate												10.90%

Shareholders_ Deficit (Details

Shareholders’ Deficit (Details Narrative) - USD ($)	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares authorized	3,000,000,000	3,000,000,000
Common stock, par value	$ 0.0001	$ 0.0001
Stock issued for services, value		$ 295,000
Common stock, shares issued	1,566,255,108	1,493,142,608
Common stock, shares outstanding	1,566,255,108	1,493,142,608
Stock To Be Issued [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Proceeds from Issuance or Sale of Equity	$ 739,500
Stock Issued During Period, Shares, New Issues	170,262,500
Stock To Be Issued [Member] | Subscription Agreements with $.008 price [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Proceeds from Issuance or Sale of Equity	$ 325,000
Stock Issued During Period, Shares, New Issues	37,812,500
Stock To Be Issued [Member] | Subscription Agreements with $.01 price [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Proceeds from Issuance or Sale of Equity	$ 304,500
Stock Issued During Period, Shares, New Issues	30,450,000
Stock To Be Issued [Member] | Subscription Agreements with $.005 price [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Proceeds from Issuance or Sale of Equity	$ 10,000
Stock Issued During Period, Shares, New Issues	2,000,000
Stock To Be Issued [Member] | Subscription Agreements with $.01 price [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Proceeds from Issuance or Sale of Equity	$ 100,000
Stock Issued During Period, Shares, New Issues	100,000,000
Officers [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued for compensation	9,612,500
Issued for compensation value	$ 124,108
Shares to be issued for compensation, shares	13,899,999
Shares to be issued for compensation, value	$ 93,660
Employee Compensation [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued for compensation	7,000,000
Issued for compensation value	$ 90,000
Vestors [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued for compensation	36,500,000
Issued for compensation value	$ 309,481
An Employee [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares to be issued for compensation, shares	65,000
Shares to be issued for compensation, value	$ 651
Series A Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized	100,000	100,000
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares issued	688	688
Preferred stock, shares outstanding	688	688
Series B Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized	62,500	62,500
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares issued	9,938	9,938
Preferred stock, shares outstanding	9,938	9,938
Series C Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized	6,944,445	6,944,445
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares issued	6,838,889	6,838,889
Preferred stock, shares outstanding	6,838,889	6,838,889
Series D Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized	500,000	500,000
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares issued	425,000	425,000
Preferred stock, shares outstanding	425,000	425,000
Series E Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized	4,000,000	4,000,000
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares issued	4,000,000	4,000,000
Preferred stock, shares outstanding	4,000,000	4,000,000
Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized	25,000,000
Preferred stock, par value	$ 0.0001
Common Stock For Services [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued for services, shares	20,000,000
Stock issued for services, value	$ 164,000

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	Jun. 30, 2023	Jun. 30, 2022
Related Party Transactions [Abstract]
Related parties – subsidiary	$ 177,320	$ 202,875
Due from related parties	0	(155,800)
Accrued salaries, bonus, fees	621,812	166,765
Total loans from related parties, net	$ 799,132	$ 58,040

Related Party Transactions (D_2

Related Party Transactions (Details Narrative) - USD ($)		12 Months Ended
	May 10, 2023	Jun. 30, 2023	Jun. 30, 2022
Related Party Transaction [Line Items]
Debt expensed		$ 13,600	$ 21,900
Accrued interest		63,015	49,415
Accrued bonus	$ 35,000
Monthly installments	5,000
Severance costs	15,000
Legal fees	15,000
Medical insurance premiums	14,000
Ms.Loria [Member]
Related Party Transaction [Line Items]
Legal fees	$ 5,000
Boapin [Member]
Related Party Transaction [Line Items]
Note payable		$ 170,000	$ 170,000

Commitments and contingencies_2

Commitments and contingencies (Details - schedule of office lease expenditures) - USD ($)	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Rent expense	$ 20,350	$ 16,605

Commitments and contingencies_3

Commitments and contingencies (Details - schedule of future minimum undiscounted lease payments) - USD ($)	Jun. 30, 2023	Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
2024	$ 16,250
2025	16,670
July & August 2025	2,790
Total future minimum lease payments	35,710
Less imputed interest	(3,203)
Total present value of future minimum lease payments	32,507
Operating lease right-of-use assets	32,157	$ 0
Operating Lease, Liability, Current	14,039	0
Long-term lease liability	$ 18,468	$ 0
Weighted Average Remaining Lease Term	2 years 2 months 1 day
Weighted Average Discount Rate	8.44%

Commitments and contingencies_4

Commitments and contingencies (Details Narrative) - USD ($)	1 Months Ended	12 Months Ended
	Sep. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Loss Contingencies [Line Items]
Monthly rent	$ 1,325		$ 1,325
Increasing annual rent, percentage	3%
Lease agreement cost		$ 43,058
Operating Lease, Cost		$ 16,270
Minimum [Member]
Loss Contingencies [Line Items]
Lease term		1 year
Maximum [Member]
Loss Contingencies [Line Items]
Lease term		3 years

Other Income - Settlement (Deta

Other Income - Settlement (Details Narrative) - USD ($)	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2019	Feb. 28, 2022
Other Income and Expenses [Abstract]
Payment for contract services			$ 97,625
Attorney costs				$ 105,125
Settlement income	$ 19,500	$ 36,000

Income Taxes (Details - Schedul

Income Taxes (Details - Schedule of Effective tax rate)	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Income Tax Disclosure [Abstract]
U.S. statutory rate	21%	21%
PA state corporate tax	9.99%	9.99%
Less valuation allowance	(30.99%)	(30.99%)
Effective tax rate	0%	0%

Income Taxes (Details - Sched_2

Income Taxes (Details - Schedule of deferred tax asset) - USD ($)	Jun. 30, 2023	Jun. 30, 2022
Income Tax Disclosure [Abstract]
Net deferred tax assets	$ 12,866,270	$ 12,217,306
Less valuation allowance	(12,866,270)	(12,217,306)
Deferred tax asset - net valuation allowance	$ 0	$ 0

Income Taxes (Details Narrative

Income Taxes (Details Narrative) - USD ($)	Jun. 30, 2023	Jun. 30, 2022
Income Tax Disclosure [Abstract]
Operating Loss Carryforwards	$ 41,517,489	$ 39,423,382